In line with in vitro cell culture observations, rapamycin treatment promoted chemokine production and IFNGR1 expression within tumor cells, suggesting a restoration of immune cell infiltration and tumor response to IFN-γ signaling (Fig. S13D, 6 J & S13E). Here, IFNGR1 is linked to neoplasm.